# An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

> **NCT00206336** · PHASE3 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Tourette Syndrome

## Interventions

- **DRUG:** Topiramate (drug)

## Key facts

- **NCT ID:** NCT00206336
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00206336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00206336, "An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00206336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*